News

Recent Developments

payloads

August 2018

Novel, potent and selective payloads with new modes of action and anchor groups with click chemistry

Useable as payloads e.g. in Antibody-Drug-Conjugates

Click here for more information.




payloads

August 2018

New analytical Standards: Microcystin-LY and Anatoxin-a

Click here to place an order.




New Collaborations

CBT Logo          GT Logo

June 2019

Cyano Biotech collaborates with Glycotope

Cyano Biotech and Glycotope started a collaboration for testing Glycotope's antibody technology and Cyano Biotech's novel payloads towards the development of ADCs for targeted cancer therapies.




CBT Logo          HDP Logo

May 2019

Cyano Biotech collaborates with Heidelberg Pharma Research

Cyano Biotech GmbH and Heidelberg Pharma Research GmbH collaborate regarding the development of Microcystin-based ADCs.




Recent Publications and Patents

Click-MCs

May 2019

From “click” to kill – Generation and application of microcystins with “clickable” features

Our poster at the Copenhagen Bioscience Conference „Natural Products - Discovery, Biosynthesis and Application“ has been awarded with a poster prize!

Click here to take a look a the poster.




Two New Patent Applications

November 2018 and January 2019

We have applied for two patents protecting our IP on microcystins as payloads for ADCs and how to generate non-ribosomal peptides with “clickable” features.

Click here to take a look a the patent applications.




ethanol

March 2017

Systems analysis of ethanol production in the genetically engineered cyanobacterium Synechococcus sp. PCC 7002

Paper published in Biotechnology for Biofuels

Click here to go to the publication.




Projects

CyFi

CyFi-EU

October 2016

CyFi CyFi - Screening for and development of novel age-modulating compounds from cyanobacteria including prediction of affected targets - granted by Investitionsbank Berlin within the framework of ProFIT. This project is co-funded by the European Regional Development Fund (EFRE).




MC

August 2015

CyanoScreen Cyano Biotech is part of a consortium working on optimizing microcystins as lead compounds against certain cancer types (for first data, click here), based on a proprietary precursor feeding approach using a novel high throughput and screening platform for cyanobacteria (click here for the publication)